Advanced Cryosurgical Systems with Integrated Predictive Analytics and Therapeutic Agent Delivery
Legal Citation
Summary of the Inventive Concept
The present inventive concept discloses next-generation cryosurgical systems that integrate real-time predictive analytics, microfluidic therapeutic agent delivery, and advanced electrolysis protocols to revolutionize cryosurgery and cold surgery treatments.
Background and Problem Solved
The original patent disclosed cryosurgical instruments combining cryosurgery and electrolysis, but had limitations in optimizing treatment protocols and delivering therapeutic agents. The present inventive concept addresses these limitations by introducing neural network-based predictive analytics, microfluidic systems, and advanced electrolysis protocols to enhance treatment outcomes and expand therapeutic capabilities.
Detailed Description of the Inventive Concept
The advanced cryosurgical system comprises a cryosurgical probe, an electrolysis module, and a neural network-based predictive analytics module. The predictive analytics module optimizes cryosurgical treatment and electrolysis protocols in real-time based on tissue temperature, pH, and electrical conductivity data. The system may also include an integrated microfluidic system for delivering therapeutic agents to the target tissue during cryosurgical treatment. Additionally, the system may incorporate a sensor array and data analytics module for real-time monitoring and adjustment of treatment protocols. The inventive concept also encompasses a method for personalized cryosurgery and electrolysis treatment planning using 3D modeling and simulation, as well as a method for cryosurgery-assisted gene editing using electrolysis to enhance gene editing efficiency.
Novelty and Inventive Step
The integration of neural network-based predictive analytics, microfluidic therapeutic agent delivery, and advanced electrolysis protocols in a single cryosurgical system constitutes a significant departure from the original patent. The use of real-time predictive analytics and microfluidic systems enables personalized and optimized treatment protocols, which is a non-obvious improvement over the prior art.
Alternative Embodiments and Variations
Alternative embodiments may include variations in the predictive analytics module, such as using different machine learning algorithms or incorporating additional data sources. The microfluidic system may be replaced with other therapeutic agent delivery mechanisms, such as nanoparticles or electroporation. The system may also be adapted for use in various medical specialties, such as oncology, dermatology, or orthopedics.
Potential Commercial Applications and Market
The advanced cryosurgical system has significant commercial potential in the medical device industry, particularly in the fields of oncology, dermatology, and orthopedics. The system's ability to optimize treatment protocols and deliver therapeutic agents in real-time may lead to improved treatment outcomes, reduced recovery times, and enhanced patient satisfaction. The market potential is substantial, with projected growth in the cryosurgery and cold surgery markets driven by increasing demand for minimally invasive and personalized treatments.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61B18/02 |
| A | A61 | A61B2017/00097 |
| A | A61 | A61B2018/00101 |
| A | A61 | A61B2018/0262 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical device technology, specifically cryosurgical and electrosurgical interventional systems, requiring advanced knowledge of medical engineering, thermal physics, and minimally invasive surgical techniques
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or medical device designer with expertise in surgical instrumentation, thermal treatment modalities, and advanced electronic control systems, holding at least a master's degree with 3-5 years of specialized experience in interventional medical technologies
Obviousness Rationale
A PHOSITA would recognize that integrating predictive analytics and microfluidic systems into existing cryosurgical probe designs represents a natural technological progression. The source patent's foundational cryosurgical probe with electrolysis capabilities provides a clear technological framework that would motivate a skilled practitioner to explore enhanced treatment optimization strategies. The proposed variations represent incremental improvements using well-established engineering techniques and known technological integration approaches.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,240 |
|---|---|
| Title | Methods, systems, and apparatuses for cryosurgery, coldsurgery, and electrolysis |
| Assignee(s) | CRYOELECTRIC SCIENCE LTD. |